The Synedica Retatrutide 40mg Injection Pen Kit is listed as an injection pen kit containing retatrutide. The supplied product information describes a kit with one pen, 12 disposable needles, and an instruction booklet.
Retatrutide is an investigational medicine being studied for its effects on metabolic processes and body weight. It acts on three receptor pathways: GLP-1, GIP, and glucagon. Its clinical development is ongoing, and its regulatory approval and availability may vary by jurisdiction.
Retatrutide should not be assumed to be an approved treatment or an established alternative to currently authorized prescription medicines. Product claims and intended uses should be checked against reliable clinical evidence and applicable regulatory guidance.
Listed product strength: 40mg. Confirm the total quantity, concentration, pen specifications, and contents with the manufacturer before publishing or purchasing.
Retatrutide is investigational, and safety, appropriate use, and regulatory status must be assessed using current authoritative information. Do not rely on seller-provided dosage schedules or use this product without guidance from a qualified healthcare professional.
Before listing or supplying this product, verify its authenticity, legal sale status, manufacturer documentation, storage requirements, and whether the product is authorized in the intended market. This product description is for general informational purposes and does not constitute medical advice.